Pages

Thursday, February 2, 2012

Cannabis Science Reports Success For 4th Brand New Self-Administering Cancer Patient

Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to introduce a 4 th cancer patient with basal cell carcinoma (skin cancer) on his left nostril, who is self-administering a topical cannabis extract and having noticeable results. Cannabis Science has received images and documented information from this 4 th patient who has basal cell carcinoma on his left nostril. The patient is enrolled in a photog...continued
 

No comments:

Post a Comment